97 related articles for article (PubMed ID: 27815312)
1. Antibody profiles induced by Trypanosoma cruzi in chagasic patients with previous or current exposure to mycobacteria.
Peverengo L; Prochetto E; Rodeles L; Valenzuela I; Marcipar IS; Bottasso O; Vicco MH
Pathog Dis; 2016 Dec; 74(9):. PubMed ID: 27815312
[TBL] [Abstract][Full Text] [Related]
2. Decreased level of antibodies and cardiac involvement in patients with chronic Chagas heart disease vaccinated with BCG.
Vicco MH; Bontempi IA; Rodeles L; Yodice A; Marcipar IS; Bottasso O
Med Microbiol Immunol; 2014 Apr; 203(2):133-9. PubMed ID: 24374613
[TBL] [Abstract][Full Text] [Related]
3. Assessment of cross-reactive host-pathogen antibodies in patients with different stages of chronic Chagas disease.
Vicco MH; Ferini F; Rodeles L; Cardona P; Bontempi I; Lioi S; Beloscar J; Nara T; Marcipar I; Bottasso OA
Rev Esp Cardiol (Engl Ed); 2013 Oct; 66(10):791-6. PubMed ID: 24773859
[TBL] [Abstract][Full Text] [Related]
4. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
Basso B; Marini V
Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
[TBL] [Abstract][Full Text] [Related]
5. IgG Autoantibodies Induced by T. cruzi During Pregnancy: Correlation with Gravidity Complications and Early Outcome Assessment of the Newborns.
Vicco MH; Rodeles L; Capovilla GS; Perrig M; Choque AG; Marcipar I; Bottasso O; Rodriguez C; Cuña W
Matern Child Health J; 2016 Oct; 20(10):2057-64. PubMed ID: 27318490
[TBL] [Abstract][Full Text] [Related]
6. A simple model for the interaction between T. cruzi and its antibodies during Chagas infection.
Isasi SC; Sibona GJ; Condat CA
J Theor Biol; 2001 Jan; 208(1):1-13. PubMed ID: 11162048
[TBL] [Abstract][Full Text] [Related]
7. Experimental Chagas disease. Innate immune response in Balb/c mice previously vaccinated with Trypanosoma rangeli. I. The macrophage shows immunological memory: Reality or fiction?
Basso B; Marini V
Immunobiology; 2014 Apr; 219(4):275-84. PubMed ID: 24321621
[TBL] [Abstract][Full Text] [Related]
8. Performance Assessment of Four Chimeric Trypanosoma cruzi Antigens Based on Antigen-Antibody Detection for Diagnosis of Chronic Chagas Disease.
Santos FL; Celedon PA; Zanchin NI; Brasil Tde A; Foti L; Souza WV; Silva ED; Gomes Yde M; Krieger MA
PLoS One; 2016; 11(8):e0161100. PubMed ID: 27517281
[TBL] [Abstract][Full Text] [Related]
9. Use of Tc-rCRP as a target for lytic antibody titration after experimental Trypanosoma cruzi infection.
Marques T; Silva GC; Henrique Paiva PM; Nascentes GAN; Ramirez LE; Norris K; Meira WSF
Exp Parasitol; 2018 Jan; 184():103-108. PubMed ID: 29246832
[TBL] [Abstract][Full Text] [Related]
10. Innovations in diagnosis and post-therapeutic monitoring of Chagas disease: Simultaneous flow cytometric detection of IgG1 antibodies anti-live amastigote, anti-live trypomastigote, and anti-fixed epimastigote forms of Trypanosoma cruzi.
Alessio GD; Côrtes DF; Machado de Assis GF; Júnior PA; Ferro EA; Antonelli LR; Teixeira-Carvalho A; Martins-Filho OA; de Lana M
J Immunol Methods; 2014 Nov; 413():32-44. PubMed ID: 25064148
[TBL] [Abstract][Full Text] [Related]
11. Molecular mimicry between Trypanosoma cruzi and host nervous tissues.
Avila JL
Acta Cient Venez; 1992; 43(6):330-40. PubMed ID: 1343745
[TBL] [Abstract][Full Text] [Related]
12. Trypanosoma rangeli: epimastigote immunogenicity and cross-reaction with Trypanosoma cruzi.
Saldaña A; Sousa OE
J Parasitol; 1996 Apr; 82(2):363-6. PubMed ID: 8604121
[TBL] [Abstract][Full Text] [Related]
13. The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease.
Junqueira C; Caetano B; Bartholomeu DC; Melo MB; Ropert C; Rodrigues MM; Gazzinelli RT
Expert Rev Mol Med; 2010 Sep; 12():e29. PubMed ID: 20840799
[TBL] [Abstract][Full Text] [Related]
14. Cellular immune response to common mycobacterial antigens in subjects seropositive for Trypanosoma cruzi.
Bottasso OA; Ingledew N; Keni M; Morini J; Pividori JF; Rook GA; Stanford JL
Lancet; 1994 Dec; 344(8936):1540-1. PubMed ID: 7983955
[TBL] [Abstract][Full Text] [Related]
15. Immune Evasion Strategies of Trypanosoma cruzi.
Flávia Nardy A; Freire-de-Lima CG; Morrot A
J Immunol Res; 2015; 2015():178947. PubMed ID: 26240832
[TBL] [Abstract][Full Text] [Related]
16. Increased Natural Killer (NK)-cell cytotoxicity and Trypanosoma cruzi-specific memory B cells in subjects with discordant serology for Chagas disease.
Elias MJ; Cesar G; Caputo MB; De Rissio AM; Alvarez MG; Lococo B; Natale MA; Albizu CL; Podhorzer A; Parodi C; Albareda MC; Laucella SA
Biochim Biophys Acta Mol Basis Dis; 2024 Aug; 1870(6):167237. PubMed ID: 38750768
[TBL] [Abstract][Full Text] [Related]
17. Antibody maturation in Trypanosoma cruzi-infected rats.
Marcipar IS; Risso MG; Silber AM; Revelli S; Marcipar AJ
Clin Diagn Lab Immunol; 2001 Jul; 8(4):802-5. PubMed ID: 11427430
[TBL] [Abstract][Full Text] [Related]
18. Molecular approaches to diagnosis of Chagas' disease: use of defined antigens and a target ribosomal RNA sequence.
Zingales B; Golgher DB; Marmorato PG; Souto RP; Gruber A
Biol Res; 1993; 26(1-2):89-100. PubMed ID: 7670551
[TBL] [Abstract][Full Text] [Related]
19. Chagas' disease: humoral response to subcellular fraction of Trypanosoma cruzi in symptomatic and asymptomatic patients.
de Titto EH; Moreno M; Braun M; Segura EL
Trop Med Parasitol; 1987 Sep; 38(3):163-6. PubMed ID: 3124252
[TBL] [Abstract][Full Text] [Related]
20. [Levels of anti-Gal antibodies in persons infected and non-infected with Trypanosoma cruzi. Probably induced by bacteria and by the parasite].
González J; Ramírez C; Seguel X; Gutiérrez B; Manque P; Porcile P; Neira I; Sagua H
Bol Chil Parasitol; 1995; 50(1-2):3-9. PubMed ID: 8573266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
